FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)

View source ↗

Summary

The FDA approved a supplemental application for Hydrocodone Bitartrate and Acetaminophen by PAI Holdings, LLC dba PAI Pharma under ANDA 040838.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• HYDROCODONE BITARTRATE AND ACETAMINOPHEN (Hydrocodone bitartrate and acetaminophen)

Snippet

SUPPL AP for HYDROCODONE BITARTRATE AND ACETAMINOPHEN (HYDROCODONE BITARTRATE AND ACETAMINOPHEN)